PHILADELPHIA — New psychology research at the University of Pennsylvania demonstrates a correlation between a test-taker’s motivation and performance on an IQ test and, more important, between that performance and a person’s future success.
PHILADELPHIA—During embryonic development, cells migrate to their eventual location in the adult body plan and begin to differentiate into specific cell types. Thanks to new research at the University of Pennsylvania, there is new insight into how these processes regulate tissues formation in the heart.
PHILADELPHIA — The advancements of our electronic age rests on our ability to control how electric charge moves, from point A to point B, through circuitry. Doing so requires particular precision, for applications ranging from computers, image sensors and solar cells, and that task falls to semiconductors.
Now, a research team at the University of Pennsylvania’s schools of Engineering and Applied Science and Arts and Sciences has shown how to control the characteristics of semiconductor nanowires made of a promising material: lead selenide.
Researchers at the University of Pennsylvania School of Medicine have devised a totally new and far more efficient way of generating induced pluripotent stem cells (iPSCs), immature cells that are able to develop into several different types of cells or tissues in the body. The researchers used fibroblast cells, which are easily obtained from skin biopsies, and could be used to generate patient-specific iPSCs for drug screening and tissue regeneration.
WHAT: “Washed Up: The Role of Water in the Collapse of Civilizations,” a public talk at the University of Pennsylvania that will provide insight into water’s impact on society
Robert Vonderheide of the School of Medicine leads a study on treating pancreatic cancer.
Researchers at the University of Pennsylvania’s Abramson Cancer Center have discovered a novel way of treating pancreatic cancer by activating the immune system to destroy the cancer’s scaffolding. The strategy was tested in a small cohort of patients with advanced pancreatic cancer, several of whose tumors shrank substantially. The team believes their findings – and the novel way in which they uncovered them -- could lead to quicker, less expensive cancer drug development.